Serological Response to Pneumococcal Vaccination in Crohn's Disease: A Prospective Multicenter Study
Interventional
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Serological response rates
Serological response rates, defined by number of patients showing adequate response to pneumococcal vaccination (at least a 2-fold increase in antipneumococcal antibodies in the serum compared with baseline)
4 weeks
No
Hyun-Soo Kim, MD, PhD
Study Chair
Yonsei University
Korea: Food and Drug Administration
CD vaccination 1.2
NCT01505855
December 2011
January 2013
Name | Location |
---|